Wang, S., Wu, C., Li, X., Zhou, Y., Zhang, Q., Ma, F., . . . Guo, P. (2017). Syringaresinol-4-O-β-d-glucoside alters lipid and glucose metabolism in HepG2 cells and C2C12 myotubes. Acta Pharm Sin B.
Styl cytowania ChicagoWang, Shuai, Chongming Wu, Xin Li, Yue Zhou, Quanyang Zhang, Fuchao Ma, Jianhe Wei, Xiaopo Zhang, i Peng Guo. "Syringaresinol-4-O-β-d-glucoside Alters Lipid and Glucose Metabolism in HepG2 Cells and C2C12 Myotubes." Acta Pharm Sin B 2017.
Styl cytowania MLAWang, Shuai, et al. "Syringaresinol-4-O-β-d-glucoside Alters Lipid and Glucose Metabolism in HepG2 Cells and C2C12 Myotubes." Acta Pharm Sin B 2017.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..